Qihui 匡

Mr. Qihui 匡

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Environmental Toxicology
Verified
Journal Article
Closed access
XLXinxin Li
Xinxin Li
LFLixiang Feng
Lixiang Feng
Q匡Qihui 匡
Qihui 匡
XWXiong Wang
Xiong Wang
JYJun Yang
Jun Yang
LLLili Li
Lili Li

29 December 2023 in Environmental Toxicology
Verified
Journal Article
Closed access
Q匡Qihui 匡
Qihui 匡
LGLikun Gao
Likun Gao
LFLixiang Feng
Lixiang Feng
XXXi Xiong
Xi Xiong
JYJun Yang
Jun Yang
PLPengcheng Luo
Pengcheng Luo

26 September 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
XLXinxin Li
Xinxin Li
Q匡Qihui 匡
Qihui 匡
Min PengMin Peng
Min Peng
KYKang Yang
Kang Yang
PLPengcheng Luo
Pengcheng Luo
The basement membrane (BM) affects the invasion and growth of malignant tumors. The role and mechanism of BM-associated lncRNAs in clear cell renal cell carcinoma (ccRCC) are unknown. In this study, we identified biomarkers of ccRCC and developed a risk model to assess patient prognosis. We downloaded transcripts and clinical data from the Cancer Genome Atlas (TCGA). Differential analysis, co-expression analysis, Cox regression analysis, and lasso regression were used to identify BM-associated prognostic lncRNAs and create a risk prediction model. We evaluated and validated the accuracy of the model using multiple methods and constructed a nomogram to predict the prognosis of ccRCC. GO, KEGG, and immunity analyses were used to explore differences in biological function. We constructed a risk model containing six BM-associated lncRNAs (LINC02154, IGFL2-AS1, NFE4, AC112715.1, AC092535.5, and AC105105.3). The risk model has higher diagnostic efficiency compared to clinical characteristics and can be used to forecast patient prognoses. We used renal cancer cells and tissue microarrays to verify the expression of lncRNAs in the risk model. We found that knocking down LINC02154 and AC112715.1 could inhibit the invasion ability of renal cancer cells. The risk model based on BM-associated lncRNAs can well predict ccRCC and guide clinical treatment.